Home/Filings/4/0001144204-17-004109
4//SEC Filing

INTERLEUKIN GENETICS INC 4

Accession 0001144204-17-004109

CIK 0001037649operating

Filed

Jan 25, 7:00 PM ET

Accepted

Jan 26, 6:07 PM ET

Size

5.6 KB

Accession

0001144204-17-004109

Insider Transaction Report

Form 4
Period: 2017-01-25
KORNMAN KENNETH S
DirectorChief Scientific Officer/Pres.
Transactions
  • Award

    Stock Option (Right to Buy)

    2017-01-25+3,625,7463,625,746 total
    Exercise: $0.12Exp: 2027-01-25Common Stock (3,625,746 underlying)
Footnotes (2)
  • [F1]The exercise price of the option is the closing price of the Issuer's common stock on the OTCQB on January 25, 2017, which was the grant date of the option.
  • [F2]The option vests as to 25% of the shares on January 25, 2018, and 1/36th of the shares on the first day of each month beginning on February 1, 2018.

Issuer

INTERLEUKIN GENETICS INC

CIK 0001037649

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001037649

Filing Metadata

Form type
4
Filed
Jan 25, 7:00 PM ET
Accepted
Jan 26, 6:07 PM ET
Size
5.6 KB